¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021 Á¦ 17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ : 2021-03-26

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021 Á¦ 17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ : 2021-03-26
±³À°ÀÏÀÚ : 2021-03-26
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021 Á¦ 17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ      
ÁÖÃÖ±â°ü : ´ëÇѹé½ÅÇÐȸ
´ã´çÀÚ : ÃÖ¼ö¿¬
¿¬¶ôó : 02-740-8364  
À̸ÞÀÏ : office@korvac.org      
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, À̺ñÀÎÈÄ°ú, °¡Á¤ÀÇÇаú¿¹¹æÀÇÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ,      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 50ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í È¸¿ø 1) Àü¹®ÀÇ,¹Ú»ç±Þ ÀÌ»ó ¼±ÀÓ ¹× Ã¥ÀÓ¿¬±¸ÀÚ: »çÀüµî·Ï 5¸¸¿ø/Ãß°¡µî·Ï 7¸¸¿ø 2) Àü°øÀÇ, ´ëÇлý, ´ëÇпø»ý ¹× ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø: »çÀüµî·Ï 3¸¸¿ø/Ãß°¡µî·Ï 5¸¸¿ø ºñȸ¿ø »çÀüµî·Ï 8¸¸¿ø/Ãß°¡µî·Ï 10¸¸¿ø (ÇöÀåµî·Ï ºÒ°¡)      
       
±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
È޽Ġ03¿ù 26ÀÏ ¿Â¶óÀΠ08:50~09:00 Opening  È²ÀÀ¼ö(¼­¿ï´ëÇб³ ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ09:00~09:30 COVID-19 global epidemiology – past, present and future prospects  Ben Cowling(È«Äá´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ09:30~10:00 SARS-CoV-2 mutations and clinical implication  ¹Ú¸¸¼º(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ10:00~10:30 Treatment strategy based on the pathogenesis of SARS-CoV-2  ±è¼ºÇÑ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ10:30~10:40 Q&A  () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ10:40~11:10 Vaccine adjuvants: classification & mode of action  À̳ª°æ(¼¼Á¾´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ11:10~11:40 Viral vector delivery system  ÃÖÁ¤¾Æ(±¹Á¦¹é½Å¿¬±¸¼Ò) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ11:40~12:10 Lipid nanoparticle for mRNA vaccine platform  ¹æÀº°æ(Çѱ¹°úÇбâ¼ú¿¬±¸¿ø) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ12:10~12:20 Q&A  () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ12:20~12:45 Rapid Development of a Highly Effective RNA-Based COVID-19 Vaccine  Philip R. Dormitzer(Pfizer) 
½Ä»ç 03¿ù 26ÀÏ ¿Â¶óÀΠ12:45~13:20 Lunch  () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ13:20~13:50 Efficacy of COVID-19 vaccines  ±èÅÂÇü(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ13:50~14:20 Safety of COVID-19 vaccines  Á¤ÈñÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ14:20~14:50 Strategies for COVID-19 vaccination: allocation, distribution, and communication  È«Á¤ÀÍ(Áúº´°ü¸®Ã») 
Åä·Ð 03¿ù 26ÀÏ ¿Â¶óÀΠ14:50~15:05 Panel discussion  () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ15:05~15:35 Interspecies transmission of zoonotic coronaviruses from SARS to COVID-19  ¼Û´ë¼·(°í·Á´ë ¾àÇдë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ15:35~16:05 SARS-CoV-2 infection in farmed minks - zoonotic concerns  °­ÇØÀº(³ó¸²Ãà»ê°Ë¿ªº»ºÎ) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:05~16:15 Q&A  () 
È޽Ġ03¿ù 26ÀÏ ¿Â¶óÀΠ16:15~16:20 Coffee break  () 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:20~16:50 Influenza, RSV and COVID-19: similar but different diseases  ±è¿¹Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ16:50~17:20 Impacts of the COVID-19 Pandemic on routine pediatric immunization  ÃÖ¿µÁØ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 03¿ù 26ÀÏ ¿Â¶óÀΠ17:20~17:30 Q&A  () 
È޽Ġ03¿ù 26ÀÏ  17:30~17:30 Closing  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021 Á¦ 17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ : 2021-03-26""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѽŰæ°úÇÐȸ ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ Ãá°èÁý´ãȸ : 2021-03-26
´ÙÀ½±Û °Ç±¹´ëÇб³ÃæÁÖº´¿ø (¿Â¶óÀÎ) ´ç´¢º´ Àν¶¸°ÆßÇÁ ¼¼¹Ì³ª : 2021-03-26
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 26 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 26 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 31 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 30 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 27 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 19 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 7 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 7 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 14 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 11 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 5 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 17 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 10 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 19 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 12 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷